獸醫再生醫學市場規模、佔有率和成長分析：按產品類型、動物種類、應用、原料類型、治療方法、最終用戶、分銷管道和地區分類——2026-2033年行業預測

2024 年全球獸醫再生醫學市場價值為 16 億美元，預計到 2025 年將成長至 18.1 億美元，到 2033 年將成長至 47.7 億美元，在預測期（2026-2033 年）內複合年成長率為 12.9%。

全球獸醫再生醫學市場專注於生物療法，例如幹細胞療法、富血小板血漿（PRP）療法和組織工程，主要應用於伴侶動物和賽馬。推動該領域發展的動力源於對微創治療日益成長的需求，這些治療能夠促進康復並維持運動功能。為了緩解慢性疼痛，飼主馴馬師不斷增加對這些療法的投入，導致終身護理成本增加，並提高了專業標準。臨床檢驗、產品開發以及商業化同種異體細胞株的建立等方面的顯著進展，促進了治療方法在全球臨床環境中的廣泛應用。關鍵的成長要素包括擴充性的科學創新，這些創新提高了可靠性、降低了成本，並增強了臨床醫生的信心。收入的成長推動了大規模臨床試驗的研究經費投入，為全球獸醫機構提供現成的療法和專業的再生醫學解決方案鋪平了道路。

全球獸醫再生醫學市場促進因素

全球獸醫再生醫學市場的發展主要得益於幹細胞技術和再生療法調查方法的顯著進步，這些進步提高了不同動物物種的治療效果。幹細胞表徵技術的改進，以及標準化處理方案和最佳化給藥方法的建立，使獸醫能夠獲得更穩定可靠的治療結果。這種可靠性的提高增強了臨床醫生對再生醫學的信心，並促使其應用範圍擴大，因為接受治療的動物的康復情況、活動能力和整體生活品質均有所改善。因此，各公司正在加大對產品開發、商業化、培訓項目和合作研究舉措的投入，最終使全球市場能夠更便捷地獲得獸醫再生醫學服務。

全球獸醫再生醫學市場面臨的限制因素

全球獸醫再生醫學市場面臨許多挑戰，其中再生醫學手術、專用耗材和專有生物材料成本高是主要原因。這些因素阻礙了再生醫學在獸醫實踐中的廣泛應用，並限制了患者的就醫途徑。許多動物醫院難以證明此類投資的合理性，尤其是在投資回報不明朗且依賴飼主是否願意接受治療的情況下。此外，地域差異導致的醫療資源匱乏和訓練有素的專家短缺加劇了就醫難的問題，造成了未被滿足的需求。這些經濟和就醫障礙可能會阻礙再生醫學融入常規診療流程，限制服務範圍的擴大，並阻礙生產者進行更廣泛的商業化推廣。

全球獸醫再生醫學市場趨勢

全球獸醫再生醫學市場正呈現出對個人化再生醫學發展的顯著趨勢，越來越注重開發專為個別動物量身定做的細胞和生物治療方法。獸醫和寵物飼主越來越傾向於選擇能夠綜合考慮物種、品種、年齡和特定損傷等多種因素，並輔以影像學和生物標記分析的治療方法。這種向客製化解決方案的轉變促使製造商開發專門的配方和全面的指導工具。此外，針對臨床醫生的個人化方案培訓以及加值服務提供者的興起，正在促進再生醫學更深入地融入臨床實踐，並提高人們對獸醫再生醫學價值的認知。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球獸醫再生醫學市場規模：依產品類型分類

• 幹細胞療法
  • 自體幹細胞療法
  • 異體幹細胞治療
• 富血小板血漿（PRP）療法
• 組織工程產品
• 基因治療
• 前驅細胞療法
• 生物材料和支架
• 其他

全球獸醫再生醫學市場規模：以動物類型分類

• 伴侶動物
  • 狗
  • 貓
  • 馬
  • 其他
• 家畜
  • 牛
  • 豬
  • 家禽
  • 其他
• 異域動物和其他動物

全球獸醫再生醫學市場規模：按應用領域分類

• 整形外科和肌肉骨骼疾病
• 創傷治療與軟組織損傷
• 神經病變
• 皮膚科
• 眼科
• 牙科和口腔疾病
• 內科
• 其他

全球獸醫再生醫學市場規模：依來源類型分類

• 脂肪來源幹細胞
• 骨髓來源幹細胞
• 臍帶來源幹細胞
• 周邊血液來源細胞
• 其他

全球獸醫再生醫學市場規模：依治療方法分類

• 細胞療法
• 生物療法
• 利用支架治療方法
• 聯合治療

全球獸醫再生醫學市場規模：依最終用戶分類

• 獸醫醫院和診所
• 獸醫專科中心
• 學術研究機構
• 獸醫復健中心
• 生物技術和製藥公司

全球獸醫再生醫學市場規模：依通路分類

• 直銷
• 銷售代理銷售
• 動物用藥品藥局和機構的採購

全球獸醫再生醫學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim Animal Health
• VetStem Biopharma
• Animal Cell Therapies Inc.
• Ardent Animal Health
• Gallant Therapeutics
• Cell Therapy Sciences
• Regenexx Veterinary
• Medrego GmbH
• Orthocell Limited
• Cook Biotech Incorporated
• Stem Cell Vet
• Kruuse Group
• Ceva Sante Animale
• Vetregen Pty Ltd
• AniCell Biotech Co., Ltd.
• QYH Biotech Co., Ltd.
• Equine Amnio Solutions
• Dechra Pharmaceuticals PLC

結論與建議

Global Veterinary Regenerative Medicine Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 4.77 Billion by 2033, growing at a CAGR of 12.9% during the forecast period (2026-2033).

Global Veterinary Regenerative Medicine focuses on biologic therapies like stem cell treatments, platelet-rich plasma, and tissue engineering for companion animals and performance horses. The sector is driven by a rising demand for minimally invasive treatments that enhance recovery and maintain mobility. Owners and trainers increasingly invest in these therapies to alleviate chronic pain, leading to heightened lifetime care expenditure and elevated professional standards. Significant advances in clinical validation, product development, and the establishment of commercial allogeneic cell lines have contributed to broader clinic adoption globally. Key growth factors include scalable scientific innovations that increase reliability and reduce costs, ensuring clinician confidence. As revenue rises, it fosters more research funding for larger trials, paving the way for off-the-shelf therapies and focused regenerative solutions in veterinary practices worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Regenerative Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Regenerative Medicine Market Segments Analysis

Global veterinary regenerative medicine market is segmented by product type, animal type, application, source type, treatment modality, end user, distribution channel and region. Based on product type, the market is segmented into Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Tissue Engineering Products, Gene Therapy, Progenitor Cell Therapy, Biomaterials & Scaffolds and Others. Based on animal type, the market is segmented into Companion Animals, Livestock Animals and Exotic & Other Animals. Based on application, the market is segmented into Orthopedic & Musculoskeletal Disorders, Wound Healing & Soft Tissue Injuries, Neurological Disorders, Dermatology, Ophthalmology, Dentistry & Oral Disorders, Internal Medicine and Others. Based on source type, the market is segmented into Adipose-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Umbilical Cord-Derived Stem Cells, Peripheral Blood-Derived Cells and Others. Based on treatment modality, the market is segmented into Cell-Based Therapy, Biologic Therapy, Scaffold-Based Therapy and Combination Therapy. Based on end user, the market is segmented into Veterinary Hospitals & Clinics, Veterinary Specialty Centers, Academic & Research Institutes, Veterinary Rehabilitation Centers and Biotech & Pharmaceutical Companies. Based on distribution channel, the market is segmented into Direct Sales, Distributor Sales and Veterinary Pharmacy & Institutional Procurement. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Regenerative Medicine Market

The global veterinary regenerative medicine market is being propelled by significant advancements in stem cell technologies and regenerative treatment methodologies, which are enhancing the effectiveness of these treatments across diverse animal species. As techniques for stem cell characterization improve, along with the establishment of standardized processing protocols and optimized delivery methods, veterinarians are achieving more consistent and reliable outcomes. This increased reliability fosters greater confidence among clinicians in utilizing regenerative therapies, leading to a rise in their adoption as reports of improved recovery, mobility, and overall quality of life in treated animals proliferate. Consequently, companies are ramping up investments in product development, commercialization efforts, training programs, and collaborative research initiatives, ultimately broadening access to regenerative veterinary services in the global marketplace.

Restraints in the Global Veterinary Regenerative Medicine Market

The Global Veterinary Regenerative Medicine market faces significant challenges due to the high expenses associated with regenerative procedures, specialized supplies, and proprietary biological materials, which restrict widespread adoption in veterinary practices and limit patient access. Many clinics struggle to justify these capital expenditures, especially when the return on investment is ambiguous and dependent on pet owners' willingness to invest in such treatments. Additionally, geographic disparities in availability and a shortage of trained professionals further exacerbate access issues, resulting in unmet demand. These financial and accessibility barriers hinder integration into general practice, restrict service expansion, and may dissuade manufacturers from pursuing broader commercialization initiatives.

Market Trends of the Global Veterinary Regenerative Medicine Market

The Global Veterinary Regenerative Medicine market is witnessing a significant trend toward personalized regenerative therapies, as there is an increasing focus on creating tailored cell and biologic treatments specifically designed for individual animals. Veterinarians and pet owners are increasingly favoring therapies that take into account various factors such as species, breed, age, and specific injury profiles, enhanced by diagnostic imaging and biomarker analytics. This movement toward customized solutions is encouraging manufacturers to produce specialized formulations and develop comprehensive guidance tools. Additionally, training clinicians in personalized protocols and the emergence of premium service providers are fostering deeper clinical integration and enhancing the perceived value of regenerative treatments in veterinary care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Regenerative Medicine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Stem Cell Therapy
  • Autologous Stem Cell Therapy
  • Allogeneic Stem Cell Therapy
• Platelet-Rich Plasma (PRP) Therapy
• Tissue Engineering Products
• Gene Therapy
• Progenitor Cell Therapy
• Biomaterials & Scaffolds
• Others

Global Veterinary Regenerative Medicine Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Livestock Animals
  • Cattle
  • Swine
  • Poultry
  • Others
• Exotic & Other Animals

Global Veterinary Regenerative Medicine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Orthopedic & Musculoskeletal Disorders
• Wound Healing & Soft Tissue Injuries
• Neurological Disorders
• Dermatology
• Ophthalmology
• Dentistry & Oral Disorders
• Internal Medicine
• Others

Global Veterinary Regenerative Medicine Market Size by Source Type & CAGR (2026-2033)

• Market Overview
• Adipose-Derived Stem Cells
• Bone Marrow-Derived Stem Cells
• Umbilical Cord-Derived Stem Cells
• Peripheral Blood-Derived Cells
• Others

Global Veterinary Regenerative Medicine Market Size by Treatment Modality & CAGR (2026-2033)

• Market Overview
• Cell-Based Therapy
• Biologic Therapy
• Scaffold-Based Therapy
• Combination Therapy

Global Veterinary Regenerative Medicine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Veterinary Specialty Centers
• Academic & Research Institutes
• Veterinary Rehabilitation Centers
• Biotech & Pharmaceutical Companies

Global Veterinary Regenerative Medicine Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributor Sales
• Veterinary Pharmacy & Institutional Procurement

Global Veterinary Regenerative Medicine Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Application, Source Type, Treatment Modality, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, Application, Source Type, Treatment Modality, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Application, Source Type, Treatment Modality, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Application, Source Type, Treatment Modality, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Application, Source Type, Treatment Modality, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetStem Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Cell Therapies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardent Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gallant Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Therapy Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regenexx Veterinary
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medrego GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthocell Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Biotech Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stem Cell Vet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kruuse Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetregen Pty Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AniCell Biotech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QYH Biotech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equine Amnio Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations